Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
538 studies found for:    "Visceral steatosis"
Show Display Options
Rank Status Study
21 Unknown  Identification of Protective and Worsening Steatohepatitis (NASH) Factors
Conditions: Morbid Obesity;   Steatohepatitis;   Steatosis
Intervention: Procedure: hepatic biopsies
22 Completed Autonomic Dysfunction in Non-Alcoholic Fatty Liver Disease
Conditions: Non-alcoholic Fatty Liver Disease;   NAFLD;   Fatty Liver, Nonalcoholic;   Nonalcoholic Fatty Liver Disease
Intervention:
23 Terminated Rifaximin in Fatty Liver Disease
Conditions: Nonalcoholic Fatty Liver Disease;   NAFLD;   Nonalcoholic Steatohepatitis
Intervention: Drug: Rifaximin
24 Terminated The Effect of Good Bacteria on Nonalcoholic Fatty Liver Disease in Diabetics
Conditions: Fatty Liver;   Hepatic Steatosis;   Diabetes Mellitus;   Liver Diseases
Intervention: Drug: Probiotic-containing powder
25 Completed Weight Management in Nonalcoholic Steatohepatitis
Condition: Fatty Liver
Intervention: Behavioral: Weight Management (diet, exercise, and behavior modification)
26 Recruiting Probiotics in the Treatment of NAFLD
Conditions: Non-alcoholic Fatty Liver Disease;   Nonalcoholic Steatohepatitis;   Fatty Liver, Nonalcoholic;   NAFLD
Intervention: Dietary Supplement: Probiotic
27 Completed Using Infrared Spectroscopy for Diagnosis Severity of Nonalcoholic Fatty Liver Disease
Conditions: Fatty Liver;   Non-alcoholic Fatty Liver Disease
Interventions: Procedure: liver biopsy;   Other: infrared spectroscopy
28 Unknown  Metformin in Non-Alcoholic Fatty Liver Disease
Condition: Fatty Liver
Intervention: Drug: metformin
29 Completed Effects of Docosahexaenoic Acid (DHA) on Children With Nonalcoholic Fatty Liver Disease (NAFLD)
Conditions: Fatty Liver;   Liver Fibrosis;   Obesity;   Metabolic Syndrome;   Nonalcoholic Fatty Liver Disease
Interventions: Drug: DHA250;   Drug: DHA500;   Drug: PLACEBO;   Behavioral: Lifestyle intervention
30 Completed Efficacy and Tolerance of Treatment With DHA, Choline and Vitamin E in Children With Non-alcoholic Steatohepatitis
Conditions: Fatty Liver;   Liver Fibrosis;   Obesity;   Metabolic Syndrome;   Nonalcoholic Fatty Liver Disease
Interventions: Drug: Docosahexaenoic Acid plus Vitamin E plus choline;   Drug: placebo pearls
31 Terminated
Has Results
Metformin for the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD)
Condition: Fatty Liver
Interventions: Drug: Glucophage (Metformin);   Drug: Placebo
32 Recruiting Treatment for Non-Alcoholic Fatty Liver With Different Doses of Vitamin E
Condition: Fatty Liver
Interventions: Drug: Vitamin E 200 IU/d;   Drug: Vitamin E 400 IU/d;   Drug: Vitamin E 800 IU/d;   Behavioral: Diet and Exercise
33 Completed Polyunsaturated Fatty Acids (PUFA) in the Treatment of Non-Alcoholic Steatohepatitis (NASH) in Patients With Type 2 Diabetes Mellitus (PUFA)
Condition: Fatty Liver
Interventions: Drug: PUFA (Opti-EPA);   Drug: Placebo
34 Completed The Effect of Helicobacter Pylori Eradication on Liver Fat Content in Non-alcoholic Fatty Liver Disease
Conditions: Fatty Liver;   Liver Dysfunction;   Insulin Resistance
Intervention: Drug: H.pylori eradication (Omeprazole, Amoxicillin, Bismuth subcitrate, Azithromycin)
35 Completed
Has Results
Pentoxifylline/Nonalcoholic Steatohepatitis (NASH) Study: The Effect of Pentoxifylline on NASH
Conditions: Nonalcoholic Steatohepatitis;   Liver Diseases
Interventions: Drug: Pentoxifylline;   Drug: Placebo
36 Terminated
Has Results
Insulin Resistance in Non-alcoholic Fatty Liver Disease
Condition: Fatty Liver
Interventions: Drug: fenofibrate;   Drug: pioglitazone;   Drug: placebo
37 Recruiting Dynamic Post-Prandial Metabolism in Patients With Non-Alcoholic Fatty Liver Disease
Conditions: Liver Disease;   Fatty Liver
Intervention:
38 Completed University of Texas H.S.C. San Antonio Pioglitazone in Non-Alcoholic Steatohepatitis Trial (UTHSCSA NASH Trial)
Conditions: Nonalcoholic Steatohepatitis;   Nonalcoholic Fatty Liver Disease;   Type 2 Diabetes Mellitus
Interventions: Drug: Pioglitazone;   Drug: Placebo
39 Completed
Has Results
Pentoxifylline in Patients With Nonalcoholic Steatohepatitis
Condition: Nonalcoholic Steatohepatitis
Interventions: Drug: pentoxifylline (PTX);   Drug: placebo
40 Terminated
Has Results
Effects Of Exenatide On Liver Biochemistry, Liver Histology And Lipid Metabolism In Patients With Fatty Liver Disease
Conditions: Diabetes Complications;   Fatty Liver
Intervention: Drug: exenatide

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years